K Pharma,Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

20

Website

www.kpharma.co.jp

Country

Japan

Exchange

Tokyo

Minato, Japan

K Pharma,Inc. develops, manufactures, and sells regenerative medicines and pharmaceutical products in Japan. It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions. Incorporated in 2016, the company is headquartered in Minato, Japan.

Key Stats

52-Week Range

¥604.00¥949.00

Beta0.42

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-85.62

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.